320
Participants
Start Date
December 1, 2021
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
solid organ malignancies treatment
Major inclusion criteria for this cohort of the study included: (1) age above 20 years; (2) presence of solid organ malignancies treated with immunotherapy, chemotherapy, Target therapy irrespective of the treatment phase; and (3) eligibility for vaccination.
RECRUITING
TuCheng Hospital, New Taipei City
Chang Gung Memorial Hospital
OTHER